Eurofins Scientific SE (EPA:ERF)
France · Delayed Price · Currency is EUR 64.08
-0.26 (-0.40%)
Jun 12, 2026, 5:35 PM CET
Eurofins Scientific SE Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 791.2 | 613.9 | 1,221 | 486.6 | 515.3 |
Cash & Short-Term Investments | 791.2 | 613.9 | 1,221 | 486.6 | 515.3 |
Cash Growth | 28.88% | -49.73% | 150.97% | -5.57% | -43.52% |
Accounts Receivable | 1,421 | 1,401 | 1,381 | 1,342 | 1,389 |
Inventory | 139.3 | 141.9 | 139 | 145.6 | 154.2 |
Other Current Assets | 301.7 | 296 | 325.7 | 339.5 | 260.3 |
Total Current Assets | 2,654 | 2,452 | 3,066 | 2,313 | 2,319 |
Net Property, Plant & Equipment | 2,763 | 2,560 | 2,297 | 2,168 | 1,830 |
Other Intangible Assets | 689.9 | 787.8 | 796 | 919.1 | 895.7 |
Goodwill | 4,657 | 4,841 | 4,551 | 4,524 | 4,115 |
Long-Term Investments | 105.5 | 117.4 | 83.6 | 83.6 | 81.7 |
Other Long-Term Assets | 116.4 | 130.3 | 93.8 | 75.7 | 90.9 |
Total Assets | 10,985 | 10,888 | 10,889 | 10,084 | 9,332 |
Accounts Payable | 678.1 | 645.9 | 600.2 | 647.7 | 627.6 |
Accrued Expenses | 79.8 | 54.7 | 59.2 | 38 | 31.4 |
Current Portion of Long-Term Debt | - | - | - | - | 253.8 |
Unearned Revenue | 217.4 | 195.9 | 192.8 | 184.2 | 163.1 |
Other Current Liabilities | 674.4 | 656.5 | 611.5 | 606.3 | 779.9 |
Total Current Liabilities | 2,430 | 2,110 | 2,122 | 1,772 | 1,856 |
Long-Term Debt | 4,432 | 3,610 | 3,927 | 3,326 | 2,500 |
Other Long-Term Liabilities | 326.8 | 340.4 | 360.8 | 430.8 | 299.1 |
Total Long-Term Liabilities | 3,979 | 3,393 | 3,630 | 3,460 | 2,799 |
Total Liabilities | 6,409 | 5,504 | 5,751 | 5,233 | 4,655 |
Common Stock | 1.8 | 1.9 | 1.9 | 1.9 | 1.9 |
Treasury Stock | -298.9 | -307.8 | -54.9 | -14.2 | -3.6 |
Additional Paid-in Capital | 1,000 | 1,000 | 1,000 | 582.7 | 1,000 |
Accumulated Other Comprehensive Income | 816.8 | 1,953 | 1,737 | 1,879 | 1,685 |
Retained Earnings | 3,024 | 2,692 | 2,394 | 2,333 | 1,964 |
Total Common Shareholders' Equity | 4,543 | 5,339 | 5,078 | 4,782 | 4,648 |
Minority Interest | 33.4 | 45.8 | 59.9 | 68.9 | 29.5 |
Shareholders' Equity | 4,577 | 5,385 | 5,137 | 4,851 | 4,677 |
Total Liabilities & Equity | 10,985 | 10,888 | 10,889 | 10,084 | 9,332 |
Total Debt | 4,432 | 3,610 | 3,927 | 3,326 | 2,754 |
Net Cash (Debt) | -3,641 | -2,996 | -2,706 | -2,839 | -2,239 |
Net Cash Per Share | -19.52 | -15.41 | -13.67 | -14.27 | -11.16 |
Book Value | 4,543 | 5,339 | 5,078 | 4,782 | 4,648 |
Book Value Per Share | 24.36 | 27.45 | 25.66 | 24.03 | 23.17 |
Tangible Book Value | -803.8 | -289.5 | -269.9 | -661.1 | -363.2 |
Tangible Book Value Per Share | -4.31 | -1.49 | -1.36 | -3.32 | -1.81 |